デフォルト表紙
市場調査レポート
商品コード
1006872

DNAシーケンシングの世界市場:将来予測 (2021年~2028年)

Global Dna Sequencing Market Forecast 2021-2028

出版日: | 発行: Inkwood Research | ページ情報: 英文 270 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
DNAシーケンシングの世界市場:将来予測 (2021年~2028年)
出版日: 2021年05月24日
発行: Inkwood Research
ページ情報: 英文 270 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のDNAシーケンシングの市場規模は、予測期間中 (2021年~2028年) に17.05%のCAGRで成長すると予測されています。市場の主な促進要因として、がんの一般症例数の増加や、ゲノムマッピングプログラムの実装、動物・植物の複製におけるDNAシーケンスのニーズの増大、リキッドバイオプシー向け利用拡大、DNAシーケンスの研究開発の進展などが挙げられます。地域別に見ると、アジア太平洋で2028年まで急速な市場成長が続く見込みです。

当レポートでは、世界のDNAシーケンシングの市場について分析し、市場の基本構造や主な促進・抑制要因、市場規模の動向見通し (過去3年間・今後9年間分)、技術別・用途別・製品別・エンドユーザー別および地域別の詳細動向、市場競争動向、主要企業のプロファイル (企業概要、主要製品/サービス、事業戦略ほか) などについて調査しております。

目次

第1章 分析範囲・手法

第2章 エグゼクティブサマリー

第3章 市場力学

  • 主な促進要因
    • 動物・植物の複製におけるDNAシーケンシングの必要性の高まり
    • 技術開発
    • DNAシーケンシング関連の研究開発 (R&D) の進展
    • がんの一般症例数の増加
    • リキッドバイオプシーの活用
    • ゲノムマッピングプログラムの実装
  • 主な抑制要因
    • 診断検査における精度・標準性への懸念
    • 新興国における熟練した専門家の不足
    • バイオインフォマティクスの限界
    • 社会的・倫理的問題

第4章 主要な分析

  • COVID-19がDNAシーケンシング市場に与える影響
  • 市場動向
  • ポーターのファイブフォース分析
  • 市場機会マトリックス
  • ベンダー情勢
  • バリューチェーン分析
  • 主な購入基準

第5章 技術別の市場

  • 合成によるシーケンシング
  • イオン半導体シーケンシング
  • チェーンターミネーション (連鎖停止) シーケンシング
  • パイロシーケンス
  • ライゲーションによるシーケンシング (SBL)
  • 単一分子リアルタイムシーケンシング (SMRT)
  • ナノポアシーケンシング
  • その他の技術

第6章 用途別の市場

  • バイオマーカーの発見
  • 診断
  • リプロダクティブ・ヘルス
  • 個別化医療
  • 創薬
  • 農業・動物研究
  • フォレンジック
  • その他の用途

第7章 製品別の市場

  • 分析装置・消耗品
    • 種類別
    • プラットフォーム別
  • シーケンシングサービス
  • バイオインフォマティクス

第8章 エンドユーザー別の市場

  • 研究センター、教育・政府機関
  • 医薬品
  • バイオテクノロジー企業
  • 病院・クリニック
  • その他のエンドユーザー

第9章 地域別の分析

  • 北米
    • 市場規模とその予測
    • 主な成長実現要因
    • 主な課題
    • 主要企業
    • 国別の分析
  • 欧州
  • アジア太平洋
  • 他の国々 (RoW)

第10章 競合情勢

  • 主要戦略の展開動向
    • 企業合併・買収 (M&A)
    • 製品の発売と開発
    • 事業提携、契約
    • 事業拡大、発表、資産売却
  • 企業プロファイル
    • ADAPTIVE BIOTECHNOLOGIES INC
    • AGILENT TECHNOLOGIES INC
    • ASURAGEN INC
    • BGI GENOMICS
    • BIO-RAD LABORATORIES INC
    • DANAHER CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
    • EUROFINS SCIENTIFIC
    • F. HOFFMANN-LA ROCHE
    • ILLUMINA INC
    • MERCK KGAA
    • PACIFIC BIOSCIENCES OF CALIFORNIA INC
    • PERKINELMER INC
    • SIEMENS HEALTHINEERS AG
    • SPIRAL GENETICS INC
    • THERMO FISHER SCIENTIFIC INC
    • UBIQUITY GENOMICS INC
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - DNA SEQUENCING
  • TABLE 2: GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL SEQUENCING BY SYNTHESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL SEQUENCING BY SYNTHESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL CHAIN TERMINATION SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL CHAIN TERMINATION SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL PYROSEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL PYROSEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL SEQUENCING BY LIGATION (SBL) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL SEQUENCING BY LIGATION (SBL) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL NANOPORE SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL NANOPORE SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL BIOMARKER DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL BIOMARKER DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL REPRODUCTIVE HEALTH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL REPRODUCTIVE HEALTH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL FORENSICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL FORENSICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL DNA SEQUENCING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL DNA SEQUENCING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL CONSUMABLES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: GLOBAL CONSUMABLES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 49: GLOBAL INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL NGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 51: GLOBAL NGS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL NGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 53: GLOBAL NGS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL RNA SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 55: GLOBAL RNA SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL TARGETED RESEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 57: GLOBAL TARGETED RESEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL WHOLE EXOME SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 59: GLOBAL WHOLE EXOME SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL WHOLE-GENOME SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 61: GLOBAL WHOLE-GENOME SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 62: GLOBAL CHIP SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 63: GLOBAL CHIP SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 64: GLOBAL DE NOVO SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 65: GLOBAL DE NOVO SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 66: GLOBAL METHYL SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 67: GLOBAL METHYL SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 68: GLOBAL SANGER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 69: GLOBAL SANGER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 70: GLOBAL SEQUENCING SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 71: GLOBAL SEQUENCING SERVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 72: GLOBAL BIOINFORMATICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 73: GLOBAL BIOINFORMATICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 74: GLOBAL DNA SEQUENCING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 75: GLOBAL DNA SEQUENCING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 76: GLOBAL RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 77: GLOBAL RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 78: GLOBAL PHARMACEUTICAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 79: GLOBAL PHARMACEUTICAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 80: GLOBAL BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 81: GLOBAL BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 82: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 83: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 84: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 85: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 86: GLOBAL DNA SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 87: GLOBAL DNA SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 88: NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 89: NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 90: LEADING PLAYERS OPERATING IN NORTH AMERICA DNA SEQUENCING MARKET
  • TABLE 91: EUROPE DNA SEQUENCING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 92: EUROPE DNA SEQUENCING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 93: LEADING PLAYERS OPERATING IN EUROPE DNA SEQUENCING MARKET
  • TABLE 94: ASIA-PACIFIC DNA SEQUENCING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 95: ASIA-PACIFIC DNA SEQUENCING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 96: LEADING PLAYERS OPERATING IN ASIA-PACIFIC DNA SEQUENCING MARKET
  • TABLE 97: REST OF WORLD DNA SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 98: REST OF WORLD DNA SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 99: LEADING PLAYERS OPERATING IN REST OF WORLD DNA SEQUENCING MARKET
  • TABLE 100: LIST OF MERGERS & ACQUISITIONS
  • TABLE 101: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 102: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 103: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 7: GLOBAL DNA SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL DNA SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL DNA SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL DNA SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL DNA SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL DNA SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL DNA SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL DNA SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION, IN 2020
  • FIGURE 16: GLOBAL DNA SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL DNA SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL DNA SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL DNA SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL DNA SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL DNA SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL DNA SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL DNA SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL DNA SEQUENCING MARKET, BY PRODUCT, IN 2020
  • FIGURE 25: GLOBAL DNA SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL NGS MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL NGS MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL NGS MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL NGS MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL NGS MARKET, BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL NGS MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 35: GLOBAL NGS MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 36: GLOBAL INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL DNA SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 38: GLOBAL DNA SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)
  • FIGURE 39: GLOBAL DNA SEQUENCING MARKET, BY END-USER, IN 2020
  • FIGURE 40: GLOBAL DNA SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2028 (IN $ MILLION)
  • FIGURE 41: GLOBAL DNA SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)
  • FIGURE 42: GLOBAL DNA SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
  • FIGURE 43: GLOBAL DNA SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
  • FIGURE 44: GLOBAL DNA SEQUENCING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
  • FIGURE 45: NORTH AMERICA DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 46: UNITED STATES DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: CANADA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: EUROPE DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 49: GERMANY DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: FRANCE DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 51: UNITED KINGDOM DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 52: ITALY DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 53: RUSSIA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 54: BELGIUM DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 55: POLAND DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 56: REST OF EUROPE DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 57: ASIA-PACIFIC DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 58: CHINA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 59: JAPAN DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 60: INDIA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 61: AUSTRALIA & NEW ZEALAND DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 62: SOUTH KOREA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 63: THAILAND DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 64: INDONESIA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 65: VIETNAM DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 66: REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 67: REST OF WORLD DNA SEQUENCING MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 68: LATIN AMERICA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 69: MIDDLE EAST & AFRICA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
目次
Product Code: 2234

KEY FINDINGS

The global DNA sequencing market growth is estimated to progress at a CAGR of 17.05% during the forecast period, 2021-2028. The market growth drivers include prevailing cancer cases, genome mapping programs implementation, increasing need for DNA sequencing in animals & plant reproduction, liquid biopsy applications, and growing R&D in DNA sequencing.

MARKET INSIGHTS

DNA sequencing helps in determining the nucleotide sequence of deoxyribonucleic acid (DNA). It has caused altering impacts in the genomics and molecular biology sectors. Genome mapping programs are on the rise globally. They increase awareness about NGS (Next-Generation Sequencing) and collect real-time sequences. They are also genetic data repositories for the world population. According to a December 2019 article, the GenomeAsia 100K consortium analyzed the genomes of 1739 people. It represented the vast genetic diversity coverage in Asia. It was launched in 2016 to understand the genome diversity of Asian ethnicities. Hosted by Nanyang Technological University, it is a non-profit consortium. At the same time, the market growth restraining factors include social & ethical issues, bioinformatics limitations, lack of skilled professionals, and accuracy concerns in diagnostic testing.

REGIONAL INSIGHTS

The geographical segmentation for the growth assessment of the global DNA sequencing market includes North America, Asia-Pacific, Europe, and Rest of World. With continuous technological innovations and the growing demand for drug discovery, Asia-Pacific is set to project the highest CAGR by 2028.

COMPETITIVE INSIGHTS

The strong competitive rivalry in the market is accredited to the price competition, innovations, and increasing adoption of new technologies. Bio-Rad Laboratories Inc, Asuragen Inc, BGI Genomics, Adaptive Biotechnologies Inc, Agilent Technologies Inc, etc., are among the market's prominent players.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING NEED FOR DNA SEQUENCING IN ANIMALS & PLANT REPRODUCTION
    • 3.1.2. TECHNOLOGICAL DEVELOPMENTS
    • 3.1.3. GROWING RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
    • 3.1.4. PREVALENCE OF CANCER CASES
    • 3.1.5. USAGE OF LIQUID BIOPSY APPLICATIONS
    • 3.1.6. IMPLEMENTATION OF GENOME MAPPING PROGRAMS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. ACCURACY AND STANDARDIZATION CONCERNS IN DIAGNOSTIC TESTING
    • 3.2.2. LACK OF SKILLED PROFESSIONALS IN EMERGING ECONOMIES
    • 3.2.3. LIMITATIONS IN BIOINFORMATICS
    • 3.2.4. SOCIAL AND ETHICAL ISSUES

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON DNA SEQUENCING MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRY
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
  • 4.7. KEY BUYING CRITERIA

5. MARKET BY TECHNOLOGY

  • 5.1. SEQUENCING BY SYNTHESIS
  • 5.2. ION SEMICONDUCTOR SEQUENCING
  • 5.3. CHAIN TERMINATION SEQUENCING
  • 5.4. PYROSEQUENCING
  • 5.5. SEQUENCING BY LIGATION (SBL)
  • 5.6. SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
  • 5.7. NANOPORE SEQUENCING
  • 5.8. OTHER TECHNOLOGIES

6. MARKET BY APPLICATION

  • 6.1. BIOMARKER DISCOVERY
  • 6.2. DIAGNOSTICS
  • 6.3. REPRODUCTIVE HEALTH
  • 6.4. PERSONALIZED MEDICINE
  • 6.5. DRUG DISCOVERY
  • 6.6. AGRICULTURE & ANIMAL RESEARCH
  • 6.7. FORENSICS
  • 6.8. OTHER APPLICATIONS

7. MARKET BY PRODUCT

  • 7.1. INSTRUMENTS & CONSUMABLES
    • 7.1.1. INSTRUMENTS & CONSUMABLES TYPE
      • 7.1.1.1. CONSUMABLES
      • 7.1.1.2. INSTRUMENTS
    • 7.1.2. INSTRUMENTS & CONSUMABLES PLATFORM
      • 7.1.2.1. NGS (NEXT GENERATION SEQUENCING)
      • 7.1.2.1.1. RNA SEQUENCING
      • 7.1.2.1.2. TARGETED RESEQUENCING
      • 7.1.2.1.3. WHOLE-EXOME SEQUENCING
      • 7.1.2.1.4. WHOLE-GENOME SEQUENCING
      • 7.1.2.1.5. CHIP SEQUENCING
      • 7.1.2.1.6. DE NOVO SEQUENCING
      • 7.1.2.1.7. METHYL SEQUENCING
      • 7.1.2.2. SANGER
  • 7.2. SEQUENCING SERVICES
  • 7.3. BIOINFORMATICS

8. MARKET BY END-USER

  • 8.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
  • 8.2. PHARMACEUTICAL
  • 8.3. BIOTECHNOLOGY COMPANIES
  • 8.4. HOSPITALS & CLINICS
  • 8.5. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. MARKET SIZE & ESTIMATES
    • 9.2.2. KEY GROWTH ENABLERS
    • 9.2.3. KEY CHALLENGE
    • 9.2.4. KEY PLAYERS
    • 9.2.5. COUNTRY ANALYSIS
      • 9.2.5.1. GERMANY
      • 9.2.5.2. FRANCE
      • 9.2.5.3. UNITED KINGDOM
      • 9.2.5.4. ITALY
      • 9.2.5.5. RUSSIA
      • 9.2.5.6. BELGIUM
      • 9.2.5.7. POLAND
      • 9.2.5.8. REST OF EUROPE
  • 9.3. ASIA-PACIFIC
    • 9.3.1. MARKET SIZE & ESTIMATES
    • 9.3.2. KEY GROWTH ENABLERS
    • 9.3.3. KEY CHALLENGE
    • 9.3.4. KEY PLAYERS
    • 9.3.5. COUNTRY ANALYSIS
      • 9.3.5.1. CHINA
      • 9.3.5.2. JAPAN
      • 9.3.5.3. INDIA
      • 9.3.5.4. AUSTRALIA & NEW ZEALAND
      • 9.3.5.5. SOUTH KOREA
      • 9.3.5.6. THAILAND
      • 9.3.5.7. INDONESIA
      • 9.3.5.8. VIETNAM
      • 9.3.5.9. REST OF ASIA-PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. MARKET SIZE & ESTIMATES
    • 9.4.2. KEY GROWTH ENABLERS
    • 9.4.3. KEY CHALLENGE
    • 9.4.4. KEY PLAYERS
    • 9.4.5. REGIONAL ANALYSIS
      • 9.4.5.1. LATIN AMERICA
      • 9.4.5.2. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS & AGREEMENTS
    • 10.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
  • 10.2. COMPANY PROFILES
    • 10.2.1. ADAPTIVE BIOTECHNOLOGIES INC
    • 10.2.2. AGILENT TECHNOLOGIES INC
    • 10.2.3. ASURAGEN INC
    • 10.2.4. BGI GENOMICS
    • 10.2.5. BIO-RAD LABORATORIES INC
    • 10.2.6. DANAHER CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
    • 10.2.7. EUROFINS SCIENTIFIC
    • 10.2.8. F. HOFFMANN-LA ROCHE
    • 10.2.9. ILLUMINA INC
    • 10.2.10. MERCK KGAA
    • 10.2.11. PACIFIC BIOSCIENCES OF CALIFORNIA INC
    • 10.2.12. PERKINELMER INC
    • 10.2.13. SIEMENS HEALTHINEERS AG
    • 10.2.14. SPIRAL GENETICS INC
    • 10.2.15. THERMO FISHER SCIENTIFIC INC
    • 10.2.16. UBIQUITY GENOMICS INC